Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to evaluate the safety of repeated doses of Botulinum Toxin Type A for the treatment of focal upper limb poststroke spasticity

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 May 2008.

1 Apr 2003 1 Apr 2008 1 Dec 2004 1 Dec 2004 1 May 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


Not available